Irritable Bowel Syndrome Regional Cohort Study
Part of Digestive system clinical trials.
This study follows a group of people with irritable bowel syndrome (IBS) to learn more about the condition. You may join if you have been diagnosed with IBS and have had normal routine blood tests.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with irritable bowel syndrome (IBS)
- You are over 18 years old
- Your recent blood work (complete blood count and C-reactive protein) was normal
- You are covered by the French social security system
- You have read the study information and agree to take part
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study checks whether a food questionnaire can reliably estimate what you eat, including certain carbs that can affect digestion (FODMAPs). It also looks at how the results relate to IBS symptoms and your self-reported physical activity.
This study follows adults with long-lasting “functional” digestive symptoms as part of routine care. It may help researchers better understand these conditions and improve how they are managed.
This study tests a self-management program designed for people with irritable bowel syndrome (IBS). It may help you learn skills to manage your symptoms and improve your daily life.
This study compares the bacteria and natural chemicals in the intestines of people with irritable bowel syndrome (IBS) to those without it. It aims to find differences that could help improve IBS diagnosis or treatment.
This study looks for signs in your body—like breath and blood tests—that can show how well you are following a special diet for IBS. It aims to find better ways to track diet compliance, which could help make dietary treatments more effective.
This trial tests a new treatment called SMT04 for people with irritable bowel syndrome (IBS), specifically the diarrhea or mixed types. It may help reduce symptoms like abdominal pain and changes in bowel habits.
Hear when a new Irritable Bowel Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.